This revised edition updates Thompson’s trail-blazing study of ethical and philosophical issues raised by biotechnology. The 1997 book was the first by a philosopher to address food and agricultural biotechnology, discussing ethical issues associated with risk assessment, labelling, animal transformation, patents, and impact on traditional farming communities. The new edition addresses the debates of the intervening decade, including cloning, the Precautionary Principle, and the biotechnology debate between the United States and Europe.

This 3rd edition of Food and Agricultural Biotechnology in Ethical Perspective updates Thompson’s analysis to reflect the next generation of biotechnology, including synthetic biology, gene editing and gene drives. The first two editions of this book, published as Food Biotechnology in Ethical Perspective in 1997 and 2007, were the first comprehensive philosophical studies of genetic engineering applied to food systems. The book is structured with chapter length treatments of risk in four categories: food safety, to animals, to the environment and socio-economic risks. These chapters are preceded by two chapters providing orientation to the uses of gene technology in food and agriculture, and to the goals, methods and background assumptions of technological ethics. There is also a chapter covering all four types of risk as applied to the first US technology, recombinant bovine somatotropin. The last four chapters take up 1) intellectual property debates, 2) religious, metaphysical and “intrinsic” objections to biotechnology, 3) issues in risk and trust and 4) a review of ethical issues in synthetic biology, gene editing and gene drives, the three key technologies that have emerged since the book was last revised.

Engineering the Farm offers a wide-ranging examination of the social and ethical issues surrounding the production and consumption of genetically modified organisms (GMOs), with leading thinkers and activists taking a broad theoretical approach to the subject. Topics covered include: the historical roots of the anti-biotechnology movement ethical issues involved in introducing genetically altered crops questions of patenting and labeling the "precautionary principle" and its role in the regulation of GMOs effects of genetic modification on the world's food supply ecological concerns and impacts on traditional varieties of domesticated crops potential health effects of GMOs Contributors argue that the scope, scale, and size of the present venture in crop modification is so vast and intensive that a thoroughgoing review of agricultural biotechnology must consider its global, moral, cultural, and ecological impacts as well as its effects on individual consumers. Throughout, they argue that more research is needed on genetically modified food and that consumers are entitled to specific information about how food products have been developed. Despite its increasing role in worldwide food production, little has been written about the broader social and ethical implications of GMOs. Engineering the Farm offers a unique approach to the subject for academics, activists, and policymakers involved with questions of environmental policy, ethics, agriculture, environmental health, and related fields.

The introduction of new technologies can be controversial, especially when they create ethical tensions as well as winners and losers among stakeholders and interest groups. While ethical tensions resulting from the genetic modification of crops and plants and their supportive gene technologies have been apparent for decades, persistent challenges remain. This book explores the contemporary nature, type, extent and implications of ethical tensions resulting from agricultural biotechnology specifically and technology generally. There are four main arenas of ethical tensions: public opinion, policy and regulation, technology as solutions to problems, and older versus new technologies. Contributions focus on one or more of these arenas by identifying the ethical tensions technology creates and articulating emerging fault lines and, where possible, viable solutions. Key features include focusing on contemporary challenges created by new and emerging technologies, especially agricultural biotechnology. Identifying a unique perspective by considering the problem of ethical tensions created or enhanced by new technologies. Providing an interdisciplinary perspective by including perspectives from sociologists, economists, philosophers and other social scientists. This book will be of interest to academics in agricultural economics, sociology and philosophy and policymakers concerned with introducing new technology into agriculture.

Genetically modified foods present numerous ethical, environmental, health and legal challenges. This report synthesizes information from many websites, scientific journals, newspapers and books that discuss the controversy surrounding genetically modified foods. The author has attempted to show that although the future applications of agrobiotechnology appear promising, the ways in which it is currently being used and regulated should be evaluated with a healthy degree of skepticism.

Agricultural biotechnology refers to a diverse set of industrial techniques used to produce genetically modified foods. Genetically modified (GM) foods are foods manipulated at the molecular level to enhance their value to farmers and consumers. This book is a collection of essays on the ethical dimensions of ag biotech. The essays were written over a dozen years, beginning in 1988. When I began to reflect on the subject, ag biotech was an exotic, untested, technology. Today, in the first year of the millenium, the vast majority of consumers in the United States have taken a bite of the apple. Milk produced by cows injected with a GM protein called recombinant bovine growth hormone (bGH), is found, unlabelled, on grocery shelves throughout the US. In 1999, half of the soybeans and cotton harvested in the US were GM varieties. Billions of dollars of public and private monies are being invested annually in biotech research, and commercial sales now reach into the tens of billions of dollars each year. I Whereas ag biotech once promised to change American agriculture, it now is in the process of doing so.